Tuberculosis and HIV infection in Brazil: Magnitude of the problem and strategies for control

Revista de Saude Publica

Volumn 41, Issue SUPPL. 1, 2007, Pages

  Jamal, Leda Fátima ^a   Moherdaui, Fábio ^b  

^a Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

Anti HIV agents, supply distribution; Antibiotics antitubercular, supply distribution; Brazil; Comorbidity; HIV infections, epidemiology; HIV infections, prevention control; Tuberculosis, epidemiology; Tuberculosis, prevention control

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; COMORBIDITY; EARLY DIAGNOSIS; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; METHODOLOGY; PATIENT COMPLIANCE; STATISTICS; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; BRAZIL; COMORBIDITY; DISEASE NOTIFICATION; DISEASE OUTBREAKS; EARLY DIAGNOSIS; HEALTH POLICY; HEALTH PROMOTION; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; TUBERCULOSIS;

EID: 36949034340     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk Factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA. 1995;274(2):143-8.
2. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359(9323):2059-64.
3. Castelo Filho A, Kritski AL. Barreto, AW, Lemos ACM, Ruffino-Netto A, Guimarães CA, et al. II Consenso Brasileiro, cle Tuberculose: Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol. 2004;30(Sup1 1):57-86
4. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restricition-fragment-length polymorphisms. N Eng J Med 1992;326:231-5.
5. Grant AD, Charambolous S, Fielding KL, Day JH, Corbett EL, Chaisson RE, et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA. 2005;293(22):2719-25.
6. Murray JF. Tuberculosis e infección por vírus de la inmunodeficiencia humana durante la década del 90. Bol Union Int Tuberc Enf Resp. 1991; 66(1):21-26.
7. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis Control in the era of HIV. Nat Rev Immunol. 2005;5(10):819-26.
8. Santo AH, Pinheirc, CE, Jordani MS. Causas básicas e associadas de morte per AIDS, Estado de São Paulo, Brasil, 1998. Rev Saude Publica. 2000;34(6):581-8.
9. Santo AH, Pinheiro CE, Jordani MS. Causas múltiplas de morte relacionadas à tuberculose no Estado de São Paulo, 1998. Rev Saude Publica. 2003;37(6):714-21.
10. Santoro-Lopes G, Pinho AM, Harrison LH, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34(4):543-6.